Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
donanemab
Marketing
Lilly's edge over rivals tipped to drive Mounjaro sales to $34B
Analysts expect Mounjaro to bring in as much in 2029 as Lilly made in 2023—and are tipping its Alzheimer’s prospect to add a further $5 billion.
Nick Paul Taylor
Apr 17, 2024 10:45am
Eisai's Leqembi launch tripped up on a host of challenges
Feb 27, 2024 9:20am
Lilly, with approval in sight, runs ad about Alzheimer's impact
Feb 15, 2024 6:55am
‘The Top Line’: The most anticipated drug launches of 2024
Feb 9, 2024 6:00am
Top 10 most anticipated drug launches of 2024
Jan 29, 2024 6:00am
Lilly embraces competition in Alzheimer's disease, exec says
Jan 12, 2024 11:43am